期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

肿瘤坏死因子拮抗剂治疗类风湿关节炎的安全性评价 被引量：6

下载PDF
导出
摘要 类风湿关节炎（Rheumatoid Arthritis，RA）是一种以累及周围关节为主的多系统性炎症性自身免疫性疾病，在全球的患病率可达1％～2％。RA在进展过程中可造成关节的破坏，甚至造成身体的残疾，严重影响患者的生活质量，因此及时、正规的治疗是非常重要的。
作者 鲍春德
机构地区 上海交通大学附属仁济医院
出处 《临床药物治疗杂志》 2008年第4期17-23,共7页 Clinical Medication Journal
关键词 类风湿关节炎 肿瘤坏死因子拮抗剂 安全性评价 治疗 自身免疫性疾病 生活质量 炎症性 患病率
分类号 R593.22 [医药卫生—内科学] R971.1 [医药卫生—药品]
  • 相关文献

参考文献33

  • 1[1]Furst DE,Breedveld FC,Kalden JR,et al.Updated consensus statement on biolagical agents,specifically tumour necrosis factor alpha(TNF alpha) blocking agents and interleukin-1 receptor antagonist(IL-1ra),for the treatment of rheumatic diseases.Ann Rheum Dis,2004,63(Suppl2):ii2-iil2
  • 2[2]Cush JJ.Biological drug use:US perspectives on indications and monitoring.Ann Rhuem Dis,2005,64(Suppl 4):iv18-iv27
  • 3[3]Pressman IS.Use of biologics for rheumatoid arthritis tempered by concerns over safety,cost.JAMA,2003,289:3229-3230
  • 4[4]Doran MF,Crowson CS,Pond GR,et al.Frequency of infection in patients with rheumatoid arthritis compared with controls:a population-hased study.Arthritis Rheum,2002,46:2287-2293
  • 5[5]Westhovens R,Yocum D,Han J,et al.The safety of infliximab,combined with background treatments,among patients with rheumatoid arthritis and various comorbiditios:a large,randomized,placebo-controlled trial.Arthritis Rheum,2006,54:1075-1086
  • 6[6]Kremer,J.,Lavelle,L.,Hinkle,K et al.Clinical Factors Associated With Infection,and Opportunistic Infection,in Patients With Rheumatoid Arthritis(RA) from the CORRONA database.Arthritis Rheum,2004,50(Suppl 9):S688
  • 7[7]Smitten AL.,Simon TA.,Suissa S,et al.The risk of cancer in patients with rheumatoid arthritis.Ann Rheum Dis,2006,65:115
  • 8[8]Ruderman EM,Markenson JA.Granulomatous infections and tumor necrosis factor antagonist therapies:update through June 2002.Presented at:Annual ELUAR Meeting; June 18-21,2003,Lisbon,Portugal
  • 9[9]Cush JJ,Kavanaugh A.ACR Hofline FDA Meeting March 2003,Update on the Safety of New Drugs for Rheumatoid Arthritis.Available at:http://www.rheumatoiogy,org/publications/hotline/ 0303TNFLp.asp? and = mem.Accessed July 1,2006
  • 10[10]Westhovens R,Yocum D,Hart J,et al.The safety of infliximab,combined with background treatments,among patients with rheumatoid arthritis and various comorbidities:a large,randomized,placebo-controlled trial Arthritis Rheum,2006,54:1075-1086

同被引文献45

  • 1陶昆(综述),卢贤瑜(审校).肿瘤坏死因子-α抗结核免疫作用研究进展[J].国际检验医学杂志,2006,27(2):143-145. 被引量：16
  • 2王莉莎,黄烽,张江林,张莉芸,邓小虎,张亚美,李晓峰,郭军华.肿瘤坏死因子拮抗剂治疗类风湿关节炎和强直性脊柱炎发生结核的风险[J].中华风湿病学杂志,2006,10(10):607-610. 被引量：18
  • 3Klinkhoff A.Biological agents for rheumatoid arthritis:targeting both physical(unction and structural damage[J].Drugs,2004,64(12):1267-1283.
  • 4Goekoop-Ruiterman YP,de Vries-Bouwstra JK,Allaart CF,et al.Patient preferences for treatment:report from a randomised comparison of treatment strategies in early rheumatoid arthritis(BeSt trial)[J].Ann Rheum Dis,2007,66(9):1227-1232.
  • 5Goekoop-Ruiterman YP,de Vries-Bouwstra JK,Allaart CF,et al.Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis(the BeSt study):A randomized,controlled trial[J].Arthritis Rheum,2008,58(Suppl 2):S126-S135.
  • 6van der Kooij SM,le Cessie S,Goekoop-Ruiterman YP,et al.Clinical and radiological efficacy of initial vs delayed treatment with infliximab plus methotrexate in patients with early rheumatoid arthritis[J].Ann Rheum Dis,2009,68(7):1153-1158.
  • 7Kremer JM,Genant HK,Moreland LW,et al.Results of a two-year followup study of patients with rheumatoid arthritis who received a combination of abatacept and methotrexate[J].Arthritis Rheum.2008,58(4):953-963.
  • 8Gordon K,Korman N,Frankel E,et al Efficacy of etanercept in an integrated multistudy database of patients with psoriasis[J].J Am Acad Dermatol,2006,54(3 Suppl2):S101-111.
  • 9Gordon KB,Langley RG,Leonardi C,et al.Clinical response to adalimumab treatment in patients with moderate to severe psoriasis:double-blind,randomized controlled trial and open-label extension study[J].J Am Acad Dermatol,2006,55(4):598-606.
  • 10Saag KG,Teng GG,Patkar NM,et al.American College of Rheumatology 2008 Recommendations for the Use of Nonbiologic and Biologic Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis[J].Arthritis Rheum.2008,59(6):762-784.

引证文献6

二级引证文献33

临床药物治疗杂志
2008年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部